ID   CSES15
AC   CVCL_B826
SY   Cedars Sinai Embryonic Stem cell 15
DR   GEO; GSM1246013
DR   NIHhESC; NIHhESC-11-0114
DR   Wikidata; Q54814577
RX   PubMed=26070610;
RX   PubMed=28445466;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0114.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=26070610; DOI=10.1016/j.stemcr.2015.05.006; PMCID=PMC4471824;
RA   Avior Y., Biancotti J.C., Benvenisty N.;
RT   "TeratoScore: assessing the differentiation potential of human
RT   pluripotent stem cells by quantitative expression analysis of
RT   teratomas.";
RL   Stem Cell Reports 4:967-974(2015).
//
RX   PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative p53 mutations.";
RL   Nature 545:229-233(2017).
//